The FDA is seeking to withdraw approval of Tavneos, a drug approved based on manipulated study data, raising complex regulatory and ethical questions about whether patients currently relying on the medication should continue to have access.
Background
The FDA has the authority to withdraw drug approvals under certain circumstances, but doing so involves complex legal and public health considerations that make it a rare and challenging action.
- Source
- Ars Technica
- Published
- Oct 31, 2026 at 07:02 PM
- Score
- 6.0 / 10